Valuation Multiple Industry Reports: Clinical Research Organizations

VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Clinical Research Organizations industry including recent transactions, market multiples, company performance and purchase price allocation percentages.

Read the full report

Industry Highlights

On October 31, 2022, Thermo Fisher Scientific Inc. announced that it entered into a definitive agreement to acquire The Binding Site Group, a global leader in specialty diagnostics, from a shareholder group led by European private equity firm Nordic Capital, in an all-cash transaction valued at £2.25 billion, or approximately $2.6 billion.
On August 1, 2022, New Mountain Capital, a growth-oriented investment firm with over $37 billion in assets under management, announced that it entered into a definitive agreement with the intention to acquire PerkinElmer’s Applied, Food and Enterprise Services businesses, a carve-out from the Discovery & Analytical Solutions segment of PerkinElmer, Inc., for up to $2.45 billion in total consideration.